Yaying Du

9PUBLICATIONS
16CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Automated software engineeringPredictive and prognostic markersMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 29, 2026
DNA methylation-mediated silencing of STAT5A drives breast cancer metastasis via dual regulation of EMT and immunosuppressive microenvironment.

|May 11, 2026
Genetically Engineered Cell Membrane-Coated Nanodrug for Targeted Treatment of Thyroid Cancer.

|Feb 20, 2026
AI-driven CRISPR screening: optimizing gene editing through automation and intelligent decision support.

Yuxi Zhao, Xingrui Li, Yaying Du

|May 27, 2024
Targeting miR-31 represses tumourigenesis and dedifferentiation of BRAF<sup>V600E</sup>-associated thyroid carcinoma.

Peitao Zhang, Lizhao Guan, Wei Sun

|Jan 26, 2023
Massively parallel knock-in engineering of human T cells.

Xiaoyun Dai, Jonathan J Park, Yaying Du

|Feb 25, 2022
MiR-205-5p/GGCT Attenuates Growth and Metastasis of Papillary Thyroid Cancer by Regulating CD44.

Han-Ning Li, Hui-Min Zhang, Xing-Rui Li

Pageof 2

Frequent Collaborators

3 joint publications

Ryan D Chow

2 joint publications

Hanning Li

2 joint publications

Jonathan J Park

2 joint publications

Sidi Chen